Average Co-Inventor Count = 2.06
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Metabolex, Inc. (5 from 41 patents)
2. Other (3 from 832,880 patents)
3. Intarcia Therapeutics, Inc. (3 from 67 patents)
4. Diatex, Inc. (1 from 10 patents)
11 patents:
1. 10869830 - Rapid establishment and/or termination of substantial steady-state drug delivery
2. 10231923 - Rapid establishment and/or termination of substantial steady-state drug delivery
3. 8481597 - Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
4. 8354448 - Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes
5. 8329749 - Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
6. 8298561 - Rapid establishment and/or termination of substantial steady-state drug delivery
7. 7576131 - Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
8. 6646004 - Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
9. 6624194 - Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
10. 6613802 - Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
11. 6262118 - Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia